Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas
- PMID: 29564694
- DOI: 10.1007/s11102-018-0881-7
Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas
Abstract
Sirtuins 1-7 (SIRT) are a highly conserved family of histone deacetylases involved in the regulation of longevity that have a considerable impact in transcription, DNA repair regulation, telomeric stability, cell senescence and apoptosis. In the present study, SIRT1-7 mRNA levels were evaluated in 37 somatotropinomas and 31 nonfunctioning pituitary adenomas (NFPAs) using qPCR and relation to tumor size, invasiveness and Ki-67 proliferative index was made. Overexpression of SIRT1 was observed in 86.5% of somatotropinomas versus 41.9% of NFPAs (P < 0.01). SIRT3 was more underexpressed in NFPAs than somatotropinomas (77.4 and 40.5%, respectively, P < 0.01) as well as SIRT4 and SIRT7. Despite the lack of association between sirtuins and invasiveness or Ki-67 index, SIRT1 and SIRT3 expressions were related to tumor size. Mean of the largest diameter was smaller in adenomas with SIRT1 overexpression than with normal expression (P < 0.01) and SIRT3 underexpression was associated with larger tumors (P < 0.01). In conclusion, a pronounced difference in sirtuins expression was identified between pituitary adenomas, suggesting that these genes are potential markers of pituitary adenomas and could be employed in the characterization of somatotropinomas and NFPAs. The role of sirtuins in pathogenesis of pituitary tumors merits further investigation and possibly will provide new molecular insight about their progression.
Keywords: Histone deacetylases; NFPA; Senescence; Sirtuins; Somatotropinomas; Tumor marker.
Similar articles
-
ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.PLoS One. 2013 Oct 2;8(10):e77406. doi: 10.1371/journal.pone.0077406. eCollection 2013. PLoS One. 2013. PMID: 24098585 Free PMC article.
-
Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium.Oncotarget. 2016 Jan 12;7(2):1144-54. doi: 10.18632/oncotarget.6691. Oncotarget. 2016. PMID: 26701732 Free PMC article.
-
Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acromegaly.J Clin Endocrinol Metab. 2009 Jun;94(6):1931-7. doi: 10.1210/jc.2008-1826. Epub 2009 Mar 17. J Clin Endocrinol Metab. 2009. PMID: 19293270 Free PMC article.
-
[Molecular basis of pituitary adenomas with emphasis on somatotropinomas].Arq Bras Endocrinol Metabol. 2004 Aug;48(4):464-79. doi: 10.1590/s0004-27302004000400006. Epub 2005 Mar 7. Arq Bras Endocrinol Metabol. 2004. PMID: 15761509 Review. Portuguese.
-
Molecular Biology of Pituitary Adenomas.Neurosurg Clin N Am. 2019 Oct;30(4):391-400. doi: 10.1016/j.nec.2019.05.001. Epub 2019 Jul 5. Neurosurg Clin N Am. 2019. PMID: 31471046 Review.
Cited by
-
SIRT1 Contributes as an Invasiveness Marker in Pituitary Adenoma.Brain Sci. 2021 Dec 11;11(12):1638. doi: 10.3390/brainsci11121638. Brain Sci. 2021. PMID: 34942940 Free PMC article.
-
The Epigenomics of Pituitary Adenoma.Front Endocrinol (Lausanne). 2019 May 14;10:290. doi: 10.3389/fendo.2019.00290. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31139150 Free PMC article. Review.
-
Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine.Endocrinol Metab (Seoul). 2023 Oct;38(5):463-471. doi: 10.3803/EnM.2023.1820. Epub 2023 Oct 13. Endocrinol Metab (Seoul). 2023. PMID: 37828709 Free PMC article. Review.
-
Architects of Pituitary Tumour Growth.Front Endocrinol (Lausanne). 2022 Jun 28;13:924942. doi: 10.3389/fendo.2022.924942. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35837315 Free PMC article. Review.
-
Novel Insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms.Endocr Rev. 2020 Dec 1;41(6):821-46. doi: 10.1210/endrev/bnaa006. Endocr Rev. 2020. PMID: 32201880 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical